Antibody-drug conjugates in acute myeloid leukemia: Commentary Journal Article


Authors: Scheinberg, D. A.; Jurcic, J. G.; Maslak, P.
Article Title: Antibody-drug conjugates in acute myeloid leukemia: Commentary
Keywords: acute granulocytic leukemia; clinical trial; neutropenia; drug efficacy; drug safety; hypertension; monotherapy; liver dysfunction; antineoplastic agent; infection; bone marrow suppression; bleeding; thrombocytopenia; hematopoietic stem cell transplantation; drug selectivity; cancer mortality; cancer resistance; asthenia; chill; drug fever; dyspnea; pneumonia; cause of death; chemotherapy induced emesis; drug response; remission; sepsis; short survey; lactate dehydrogenase; safety; hyperbilirubinemia; leukemia relapse; brain hemorrhage; lactate dehydrogenase blood level; myeloid progenitor cell; multidrug resistance; cd33 antigen; gemtuzumab ozogamicin; liver venoocclusive disease; acute myeloid leukemia; calicheamicin
Journal Title: Nature Clinical Practice Oncology
Volume: 3
Issue: 5
ISSN: 1743-4254
Publisher: Nature Publishing Group  
Date Published: 2006-05-01
Start Page: 238
End Page: 239
Language: English
DOI: 10.1038/ncponc0478
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 1" - "Export Date: 4 June 2012" - "Source: Scopus"
Altmetric
Citation Impact
MSK Authors
  1. Joseph G Jurcic
    134 Jurcic
  2. Peter Maslak
    195 Maslak